Now showing items 1-2 of 2
The contribution of CI to the strategic decision making process: Empirical study of the European pharmaceutical industry.
(Society of Competitive Intelligence Professionals., 2006)
The practice of Competitive Intelligence (CI) is common in the US pharmaceutical industry but there is little evidence to suggest that the European industry has adopted CI to the same extent. This study reports on a specific ...
Characteristics of competitive intelligence practice in R&D driven firms: Evidence from the UK pharmaceutical industry.
The greatest proportion of Competitive Intelligence (CI) practice in the pharmaceutical industry is located within the R&D function (Halliday et al 1992). This paper reports on the results of an empirical study into the ...